학술논문

Doxorubicin vs epirubicin, report of a second-line randomized phase II/III study in advanced breast cancer. EORTC Breast Cancer Cooperative Group.
Document Type
journal article
Source
British Journal of Cancer; Jun1998, Vol. 77 Issue 12, p2257-2263, 7p
Subject
Language
ISSN
00070920